<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        95-368-07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2007
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RABEZOLE 10MG E.C. TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        RABEPRAZOLE SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        24.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory  Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BC04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Rabezole&trade; tablet contains the active ingredient rabeprazole sodium. This belongs to<br />a group of medicines called &lsquo;Proton Pump Inhibitors&rsquo; (PPIs). They work by lowering<br />the amount of acid that your stomach produces.<br />Rabezole&trade; tablets are used to treat the following conditions:<br />- &lsquo;Gastro-oesophageal reflux disease&rsquo; (GORD), which can include heartburn. GORD<br />is caused when acid and food from your stomach escapes into your food pipe<br />(oesophagus).<br />- Ulcers in your stomach or the upper part of your gut (intestine). If these ulcers are<br />infected with bacteria called &lsquo;Helicobacter pylori&rsquo; (H. Pylori), you will also be given<br />antibiotics. Using Rabezole&trade; tablets and antibiotics together gets rid of the infection<br />and makes the ulcer heal. It also stops the infection and ulcer from coming back.<br />- Zollinger-Ellison Syndrome where your stomach produces too much acid.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Rabezole&trade; if:<br />- You are allergic (hypersensitive) to rabeprazole sodium, or any of the other<br />ingredients of Rabezole&trade; (listed in Section 6 below).<br />- You are pregnant or think that you are pregnant.<br />- You are breast-feeding.<br />Do not use Rabezole&trade; if any of the above apply to you. If you are not sure, talk to<br />your doctor or pharmacist before using Rabezole&trade;. Also see Pregnancy and<br />breast-feeding section.<br />Children<br />Rabezole&trade; should not be used in children.<br />Take special care with Rabezole&trade;<br />Check with your doctor or pharmacist before taking Rabezole&trade; if:<br />- You are allergic to other proton pump inhibitor medicines or &#39;substituted<br />benzimidazoles&#39;.<br />- Blood and liver problems have been seen in some patients but often get better when<br />Rabezole&trade; is stopped.<br />- You have a stomach tumour.<br />- You have ever had liver problems.<br />- If you are taking atazanavir- for HIV infection.<br />If you are not sure if any of the above apply to you, talk to your doctor or pharmacist<br />before using Rabezole&trade;.<br />If you experience severe (watery or bloody) diarrhoea with symptoms such as fever,<br />abdominal pain or tenderness, stop taking Rabezole&trade; and see a doctor straight away.<br />Subacute cutaneous lupus etythematosus (SCLE):<br />Proton pump inhibitors are associated with very infrequent cases of SCLE. If lesions<br />occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia,<br />the patient should seek medical help promptly and the health care professional should<br />consider stopping this medication. SCLE after previous treatment with a proton pump<br />inhibitor may increase the risk of SCLE with other proton pump inhibitors.<br />Using other medicines<br />Please tell your doctor or pharmacist if you are taking or have recently taken any<br />other medicines. This includes medicines obtained without a prescription, including<br />herbal medicines.<br />In particular, tell your doctor or pharmacist if you are taking any of the following<br />medicines:<br />- Ketoconazole or itraconazole used to treat infections caused by a fungus.<br />Rabezole&trade; may lower the amount of this type of medicine in your blood. Your<br />doctor may need to adjust your dose.<br />- Atazanavir used to treat HIV-infection. Rabezole&trade; may lower the amount of this<br />type of medicine in your blood and they should not be used together.<br />If you are not sure if any of the above apply to you, talk to your doctor or pharmacist<br />before using Rabezole&trade;.<br />Pregnancy and breast-feeding<br />- Do not use Rabezole&trade; if you are pregnant or think you may be pregnant.<br />- Do not use Rabezole&trade; if you are breast-feeding or planning to breast-feed.<br />Ask your doctor or pharmacist for advice before taking any medicine during<br />pregnancy or while breast-feeding.<br />Driving and using machines<br />You may feel sleepy while taking Rabezole&trade;. If this happens, do not drive or use<br />any tools or machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Rabezole&trade; exactly as your doctor has told you. You should check with<br />your doctor or pharmacist if you are not sure.<br />Taking this medicine<br />- Only remove a tablet from the blister strip when it is time to take your medicine.<br />- Swallow your tablets whole with a drink of water. Do not chew or crush the tablets.<br />- Your doctor will tell you how many tablets to take and how long to take them for.<br />This will depend on your condition.<br />- If you are taking this medicine for a long time, your doctor will want to monitor<br />you.<br />Adults and the Elderly<br />For &lsquo;gastro-oesophageal reflux disease&rsquo; (GORD)<br />Treatment of moderate to severe symptoms (symptomatic GORD)<br />- The usual dose is one Rabezole&trade; 10 mg tablet once a day for up to 4 weeks.<br />- Take the tablet in the morning before eating.<br />- If your condition returns after 4 weeks treatment, your doctor may tell you to take<br />one Rabezole&trade; 10 mg tablet as and when you require it.<br />Treatment of more severe symptoms (erosive or ulcerative GORD)<br />- The usual dose is one Rabezole&trade; 20 mg tablet once a day for 4 to 8 weeks.<br />- Take the tablet in the morning before eating.<br />Long-term treatment of symptoms (GORD maintenance)<br />- The usual dose is one Rabezole&trade; 10 mg or 20 mg tablet once a day for as long as<br />your doctor has told you.<br />- Take the tablet in the morning before eating.<br />- Your doctor will want to see you at regular intervals to check your symptoms and<br />dosage.<br />For ulcers of the stomach (peptic ulcers)<br />- The usual dose is one Rabezole&trade; 20 mg tablet once a day for 6 weeks.<br />- Take the tablet in the morning before eating.<br />- Your doctor may tell you to take Rabezole&trade; for another 6 weeks if your condition<br />does not improve.<br />For ulcers of the intestine (duodenal ulcers)<br />- The usual dose is one Rabezole&trade; 20 mg tablet once a day for 4 weeks.<br />- Take the tablet in the morning before eating.<br />- Your doctor may tell you to take Rabezole&trade; for another 4 weeks if your condition<br />does not improve.<br />For ulcers caused by H. Pylori infection and to stop them coming back<br />- The usual dose is one Rabezole&trade; 20 mg tablet twice a day for seven days.<br />Your doctor will also tell you to take antibiotics called amoxicillin and<br />clarithromycin.<br />For further information on the other medicines used for the H. Pylori treatment, see<br />the individual product information leaflets.<br />Zollinger-Ellison Syndrome where excess acid is produced in the stomach<br />- The usual dose is three Rabezole&trade; 20 mg tablets once a day to start with.<br />- The dose may then be adjusted by your doctor depending on how you respond to<br />the treatment.<br />If you are on long-term treatment you will need to see your doctor at regular intervals<br />for review of your tablets and symptoms.<br />Children: The product should not be used in children.<br />Patients with liver problems: You should consult your doctor who will take special<br />care when beginning treatment with Rabezole&trade; and while you continue to be treated<br />with Rabezole&trade;.<br />If you take more Rabezole&trade; than you should<br />If you take more Rabezole&trade; than you should, talk to a doctor or go to a hospital<br />straight away. Take the medicine pack with you.<br />If you forget to take Rabezole&trade;<br />- If you forget to take a dose, take it as soon as you remember it. However, if it is<br />almost time for your next dose, skip the missed dose and continue as usual.<br />- If you forget to take your medicine for more than 5 days, talk to your doctor before<br />taking any more medicine.<br />- Do not take a double dose (two doses at the same time) to make up for a forgotten dose.If you stop taking Rabezole&trade;<br />Relief of symptoms will normally occur before the ulcer has completely healed.<br />It is important that you do not stop taking the tablets until told to do so by your<br />doctor.<br />If you have any further questions on the use of this product, ask your doctor or<br />pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Rabezole&trade; can cause side effects, although not everybody gets<br />them. The side effects are usually mild and improve without you having to stop<br />taking this medicine.<br />Stop taking Rabezole&trade; and see a doctor straight away if you notice any of the<br />following side effects - you may need urgent medical treatment:<br />- Allergic reactions-the signs may include: sudden swelling of your face, difficulty<br />breathing or low blood pressure which may cause fainting or collapse.<br />- Frequent infections, such as a sore throat or high temperature (fever), or ulcers in<br />your mouth or throat.<br />- Bruising or bleeding easily.<br />These side effects are rare (affect less than 1 in 1,000 people).<br />- Severe skin blistering, or soreness or ulcers in your mouth and throat.<br />These side effects are very rare (affect fewer than 1 in 10,000 people).Other possible side effects:<br />Common (affect less than 1 in 10 people)<br />- Infections<br />- Difficulty sleeping<br />- Headache or feeling dizzy<br />- Cough, runny nose or sore throat (pharyngitis)<br />- Effects on your stomach or gut such as stomach pain, diarrhoea, wind (flatulence),<br />feeling sick (nausea), being sick (vomiting) or constipation<br />- Aches or back pain<br />- Weakness or flu-like symptoms.<br />Uncommon (affect less than 1 in 100 people)<br />- Feeling nervous or drowsy<br />- Chest infection (bronchitis)<br />- Painful and blocked sinuses (sinusitis)<br />- Dry mouth Indigestion or belching<br />- Skin rash or redness<br />- Muscle, leg or joint pain<br />- Bladder infection (urinary tract infection)<br />- Chest pain<br />- Chills or fever<br />- Changes in how your liver is working (shown in blood tests).<br />Rare (affect less than 1 in 1,000 people)<br />- Loss of appetite (Anorexia). - Depression<br />- Hypersensitivity (includes allergic reactions)<br />- Visual disturbance<br />- Sore mouth (stomatitis) or taste disturbance<br />- Upset stomach or stomach pain<br />- Liver problems including yellowing of your skin and whites of your eyes (jaundice)<br />- Itchy rash or blistering skin<br />- Sweating<br />- Kidney problems<br />- Weight gain<br />- Changes in white blood cells (shown in blood tests) which may result in frequent<br />infection<br />- Reduction in blood platelets resulting in bleeding or bruising more easily than<br />normal.<br />Other possible side effects (unknown frequency)<br />- Breast swelling in men<br />- Fluid retention<br />- Low blood levels of sodium which can cause tiredness and confusion, muscle<br />twitching, fits and coma<br />- Patients who have previously had liver problems may very rarely get<br />encephalopathy (a brain disease).<br />Do not be concerned by this list of side effects. You may not get any of them. If any<br />of the side effects get serious, or if you notice any side effects not listed in this leaflet,<br />please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not store above 25 &ordm;C. Protect from light.<br />Do not use Rabezole&trade; after the expiry date which is stated on the carton and blister<br />foil.<br />Medicines should not be disposed of via wastewater or household waste. Ask your<br />pharmacist how to dispose of medicines that are no longer required. These measures<br />will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Rabezole&trade; contains<br />Each Rabezole&trade; 10 mg tablet contains 10 mg of the active substance rabeprazole<br />sodium.<br />Each Rabezole&trade; 20 mg tablet contains 20 mg of the active substance rabeprazole<br />sodium.<br />The other ingredients are: Ludipress, Crospovidone, Magnesium oxide,<br />Microcrystalline Cellulose (Avicel), Povidone K-30, Hydroxypropylcellulose,<br />Colloidal Silicon Dioxide (Aerosil 200), Magnesium Stearate , Opadry White,<br />Hydroxypropyl cellulose AS (Aqoat HF), Sodium Hydroxide, Ammonia 30 %,<br />Acryl-eze, Purified Water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Rabezole™ 10 mg : Off white to pale yellow coloured biconvex enteric-coated tablets
imprinted 'JP 52' on both sides with black ink.
Rabezole™ 20 mg : Off white to pale yellow coloured biconvex enteric-coated tablets
imprinted 'JP 53' on both sides with black ink.
Rabezole™ 10 mg: Pack of 2 blisters of 7 enteric coated tablets each.
Rabezole™ 20 mg: Pack of 2 blisters of 7 enteric coated tablets each.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Jamjoom Pharmaceuticals Co., Jeddah, Saudi Arabia.<br />Tel: +966-12-6081111, Fax: +966-12-6081222.<br />Website: www.jamjoompharma.com<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222,<br />Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                01/2017
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>على رابيبرازول صوديوم كمادة فعالة وهي مادة تنتمي إلى فئة من الأدوية &trade; تحتوي أقراص رابيزول<br />تسمى &quot;مثبطات ضخ البروتون&quot; وهي تعمل على تقليل كمية الحمض الذي تنتجه المعدة.<br />لعلاج الحالات الآتية: &trade; تستخدم أقراص رابيزول<br />- الارتجاع المعدي المريئي بما يمكن أن يتضمنه من حرقة المعدة حيث يهرب الحمض من داخل المعدة<br />إلى قناة الطعام (المرئ).<br />- قرحة في المعدة أو الجزء العلوي من الأمعاء (الإثنا عشر). في حالات القرح التي تسببها عدوى<br />لبكتيريا تسمى (هيليكوباكتر بايلوري) يمكن أن يصف الطبيب لك مضادا حيويا لعلاج العدوى بجانب<br />ومن ثم يمكن للقرحة ان تلتئم كما تمنع عودة القرحة مرة أخرى. &trade; أقراص رابيزول<br />- متلازمة زولينجر إيليسون حيث تفرز المعدة كمية كبيرة جدا من الحمض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&trade; لا تستخدم رابيزول<br />الاخرى &trade; - كان لديك حساسية (فرط حساسية) ضد رابيبرازول صوديوم أو أي من مكونات رابيزول<br />والمذكورة في الجزء رقم ٦ في هذه النشرة<br />- كنتِ حاملاً أو تشكين في كونك حاملاً<br />- كنتِ مرضعة<br />إذا انطبقت عليك أي حالة من المذكور أعلاه. إذا كنت غير متأكد تحدث إلى طبيبك &trade; لا تستخدم رابيزول<br />.&trade; أو الصيدلى قبل استخدام رابيزول<br />انظر أيضا الجزء الخاص بالحمل والإرضاع في هذه النشرة.<br />الأطفال<br />مع الأطفال &trade; يجب أن لا يستخدم رابيزول<br />بحذر : &trade; استخدم رابيزول<br />إذا: &trade; راجع طبيبك أو الصيدلي قبل استخدام رابيزول<br />- كان لديك حساسية ضد أي من مثبطات ضخ البروتون الأخرى أو &quot; البنزيميدازولات المستبدلة&quot;<br />- ظهور مشاكل في الدم والكبد عند بعض المرضى ولكنها عادة تنتهي مع التوقف عن تناول الدواء<br />- كان لديك ورم في المعدة<br />- سبق لك الإصابة بمشاكل في الكبد.<br />- كنت تستخدم دواء يحتوي علي مادة أتازانافير [تستخدم في حالات فيروس نقص المناعة المكتسب<br />(إتش آي في)]<br />إذا لم تكن متاكدا بشأن انطباق الحالات المذكورة أعلاه عليك من عدمه، يرجى استشارة الطبيب أو<br />&trade; الصيدلي قبل استخدامك رابيزول<br />إذا أصبت بإسهال شديد (مائي أو دموي) مع أعراض مثل الحمَى أو ألم في البطن أو عند ملامسة البطن،<br />وقم بزيارة الطبيب على الفور. &trade; توقف عن استخدام رابيزول<br />:(SCLE) الذئبة الحمامية الجلدية تحت الحادة<br />في .(SCLE) ترتبط مثبطات مضخة البروتون مع حالات نادرة جداً من الذئبة الحمامية الجلدية تحت الحادة<br />حالة حدوث ضرر، وخاصة في مناطق الجلد المعرضة للشمس، وإذا كان يرافقه ألم مفصلي، ينبغي على<br />المريض طلب المساعدة الطبية فوراً وينبغي على الممارس الصحي أن ينظر في وقف هذا الدواء. حدوث<br />بعد علاج سابق مع مثبطات مضخة البروتون قد يزيد من خطر (SCLE) الذئبة الحمامية الجلدية تحت الحادة<br />مع غيرها من مثبطات مضخة البروتون. (SCLE) الذئبة الحمامية الجلدية تحت الحادة<br />استخدام الأدوية الأخرى<br />يرجى إخبار الطبيب إذا كنت تتناول أو تناولت منذ فترة وجيزة أي أدوية أخرى بما في ذلك الأدوية التي<br />قمت بتناولها دون وصفة طبية وكذلك أي علاج بالأعشاب.<br />أخبر طبيبك إذا كنت تتناول أي من الأدوية التالية بشكل خاص:<br />في خفض &trade; - كيتوكونازول، ايتراكونازول والتي تستخدم في علاج عدوى الفطريات. قد يتسبب رابيزول<br />كمية هذه الأدوية في الدم ولذلك قد يحتاج طبيبك إلى تعديل جرعة هذه الأدوية.<br />من &trade; - أتازانافير يستخدم في حالات فيروس نقص المناعة المكتسب (إتش آي في). قد يقلل رابيزول<br />كمية هذا الدواء في الدم ولذلك لا يجب استخدامهما معا.<br />إذا لم تكن متاكدا بشأن انطباق الحالات المذكورة أعلاه عليك من عدمه، يرجى استشارة الطبيب أو<br />&trade; الصيدلي قبل استخدامك رابيزول<br />الحمل والإرضاع<br />إذا كنتِ حاملاً أو تشكين في كونك حاملاً &trade; لا تستخدمي رابيزول<br />إذا كنتِ مرضعة او تخططين للإرضاع . &trade; لا تستخدمي رابيزول<br />استشيري الطبيب أو الصيدلي قبل استخدام أي دواء خلال فترتي الحمل والإرضاع.<br />قيادة المركبات وتشغيل الآلات<br />إذا حدث ذلك لا تقم بقيادة المركبات أو تشغيل الآلات. .&trade; قد تشعر بالنعاس عند استخدامك رابيزول<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تماما كما أخبرك الطبيب. يجب عليك مراجعة الطبيب أو الصيدلي إذا لم تكن &trade; دائما استخدم رابيزول<br />متأكداً.<br />تناول هذا الدواء<br />- قم بإخراج قرص واحد من شريط الأقراص فقط حينما يحين موعد الجرعة.<br />- ابتلع القرص كاملا مع شربة ماء، لا تقم بمضغها أو تحطيمها في فمك.<br />- سيخبرك الطبيب عن عدد الأقراص الذي ستستخدمها والمدة التي ستستمر خلالها في تناول العلاج<br />وذلك وفقا لحالتك.<br />- سيحتاج الطبيب إلى متابعة حالتك باستمرار في حال استخدامك هذا الدواء لفترات طويلة.<br />البالغين وكبار السن<br />لعلاج الحالات البسيطة إلى متوسطة من الارتجاع المعدي المريئي<br />- الجرعة الاعتيادية هي قرص ۱۰ ملجم مرة واحدة يوميا ولمدة ٤ أسابيع<br />- قم بتناول القرص في الصباح قبل الأكل<br />- إذا عادت الحالة من جديد بعد ٤ أسابيع من العلاج فمن الممكن أن يطلب منك الطبيب استخدام قرص<br />۱۰ ملجم وقتما تشعر بالحاجة لذلك.<br />لعلاج الحالات الأكثر حدة من الارتجاع المعدي المريئي (الارتجاع المعدي المريئي التآكلي أو التقرحي)<br />۸ أسابيع - - الجرعة الاعتيادية هي قرص ۲۰ ملجم مرة واحدة يوميا ولمدة ٤<br />- قم بتناول القرص في الصباح قبل الأكل<br />العلاج طويل الأجل للأعراض (العلاج المحافظ)<br />- الجرعة الاعتيادية هي قرص ۱۰ أو ۲۰ ملجم مرة واحدة يوميا واستمر في التعاطي للمدة التي يحددها<br />لك الطبيب.<br />- قم بتناول القرص في الصباح قبل الأكل<br />- سيحتاج الطبيب لمتابعتك بانتظام على فترات زمنية محددة لمراجعة الجرعة وفحص الأعراض.<br />لعلاج حالات الإصابة بقرحة المعدة<br />- الجرعة الاعتيادية هي قرص ۲۰ ملجم مرة واحدة يوميا لمدة ٦ أسابيع<br />- قم بتناول القرص في الصباح قبل الأكل<br />- قد يطلب منك الطبيب الاستمرار في التناول لمدة ٦ أسابيع أخرى إذا لم تتحسن حالتك<br />لعلاج ومنع تكرار حدوث حالات الإصابة بالقرح نتيجة عدوى إتش بايلوري<br />- الجرعة الاعتيادية هي قرص ۲۰ ملجم مرتين يوميا ولمدة ۷ أيام.<br />- سيطلب منك الطبيب أيضا استخدام مضادات حيوية تسمى أموكسيسيللين و كلاريثرومايسين.<br />لمزيد من المعلومات حول الأدوية الأخرى التي تستخدم في علاج عدوى إتش بايلوري يرجى مراجعة<br />نشرة معلومات كل دواء.<br />لعلاج متلازمة زولينجر إيليسون (تفرز المعدة كمية كبيرة جدا من الحمض)<br />- الجرعة الاعتيادية هي قرص ۲۰ ملجم مرة يوميا كجرعة مبدئية<br />- قد يتم تعديل الجرعة من جانب الطبيب وذلك وفقا لمدى استجابتك للعلاج<br />إذا كنت تتناول الدواء لفترات طويلة فسوف تحتاج لمراجعة الطبيب بانتظام على فترات زمنية محددة<br />لمراجعة الجرعة وفحص الأعراض.<br />الأطفال: يحظر استخدام هذا الدواء في حالات الأطفال.<br />لمرضى الكبد<br />وأثناء فترة &trade; يجب استشارة الطبيب والذي سيقدم لك عناية خاصة عندما تبدأ في استخدام رابيزول<br />استخدامك للعلاج.<br />بكمية أكثر مما ينبغي &trade; إذا تعاطيت رابيزول<br />بكمية أكثر مما ينبغي اتصل بطبيبك أو بالمستشفى على الفور واصطحب معك &trade; إذا تناولت رابيزول<br />عبوة الدواء.<br />&trade; إذا نسيت أن تتعاطى رابيزول<br />في موعدها المحدد فقم بتناولها بمجرد أن تتذكر ذلك. إذا كان &trade; - إذا نسيت أن تتناول جرعة رابيزول<br />موعد الجرعة التالية قد أوشك على المجئ فلا تتناول الجرعة الفائتة وتناول الجرعة الجديدة في موعدها<br />المحدد.<br />- إذا نسيت أن تتناول الدواء لمدة أكثر من ٥ أيام، تحدث إلى طبيبك قبل تتناول أي كمية أخرى من<br />الدواء.<br />- لا تتناول ضعف الجرعة لتعويض أي جرعة فائتة.</p><p>إذا توقفت عن تناول رابيزول<br />الشعور بتخفيف الأعراض يحدث عادة قبل التئام القرحة بشكل كامل<br />من المهم أن لا تتوقف عن تناول الدواء مالم يطلب الطبيب ذلك منك.<br />إذا كان لديك المزيد من الأسئلة حول استخدام هذا الدواء. استشر طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>٤. الآثار الجانبية المحتملة.<br />أن يتسبب في تأثيرات جانبية ولكنها لا تصيب كل &trade; كما هو الحال مع كل الأدوية، يمكن لرابيزول<br />الأشخاص.<br />عادة ما تكون هذه الآثار بسيطة وتتحسن دون الحاجة إلى التوقف عن تناول الدواء<br />واستشر طبيبك على الفور إذا لاحظت ظهور أي من الأثار الجانبية التالية &trade; توقف عن استخدام رابيزول<br />(قد تحتاج إلى علاج طبي عاجل):<br />- تفاعل تحسسي، تشمل أعراضه: تورم مفاجئ في الوجه، صعوبة في التنفس أو انخفاض في ضغط الدم<br />قد يؤدي إلى الإغماء أو الهبوط.<br />- تكرار الإصابة بالعدوى مثل التهاب الحلق أو الحمى أو القرح في الفم أو الحلق.<br />- الكدمات أو سهولة النزف<br />الأعراض الجانبية السابقة نادرة (تحدث في أقل من ۱ من ۱۰۰۰ شخص يتعاطون الدواء)<br />- تبثر حاد في الجلد أو تقرح في الفم أو الحلق<br />الأعراض الجانبية السابقة نادرة جدا (تحدث في أقل من ۱ من ۱۰۰۰۰ شخص يتعاطون الدواء)<br />الآثار الجانبية الأخرى<br />الآثار الجانبية الشائعة (تحدث في أقل من ۱ من ۱۰ أشخاص يتعاطون الدواء):<br />- العدوى<br />- صعوبة في النوم<br />- الصداع او الشعور بالدور<br />- السعال، رشح الأنف، احتقان الحلق (التهاب البلعوم)<br />- تأثيرات على المعدة أو القناة الهضمية مثل: ألم في المعدة، إسهال، ريح (انتفاخ)، الغثيان، القئ،<br />الإمساك.<br />- أوجاع أو ألم في الظهر.<br />- وهن أو أعراض شبيهة بالأنفلونزا<br />الآثار الجانبية غير الشائعة (تحدث في أقل من ۱ من ۱۰۰ شخص يتعاطون الدواء):<br />- الشعور بالتوتر أو النعاس<br />- عدوى الصدر (التهاب الشعب الهوائية)<br />- ألم وانسداد في الجيوب الانفية (التهاب الجيوب الأنفية)<br />- جفاف الفم أو عسر الهضم او التجشؤ<br />- طفح جلدي أو احمرار.<br />- ألم في العضلات أو الأرجل أو المفاصل<br />- عدوى المثانة (عدوى المسالك البولية)<br />- ألم في الصدر<br />- قشعريرة أو حٌمى<br />- تغير في كيفية عمل الكبد (تظهر في فحوصات الدم)<br />الآثار الجانبية النادرة (تحدث في أقل من ۱ من ۱۰۰۰ شخص يتعاطون الدواء):<br />- فقدان الشهية<br />- الاكتئاب<br />- فرط الحساسية (بما في ذلك التفاعل التحسسي)<br />- تقرح الفم (التهاب الفم) أو اضطراب في حاسة التذوق<br />- اضطراب أو ألم في المعدة<br />- مشاكل في الكبد بما في ذلك اصفرار الجلد والجزء الأبيض من العين (الصفراء)<br />- طفح جلدي حاك أو تبثر الجلد<br />- التعرق<br />- مشاكل في الكلى<br />- زيادة الوزن<br />- تغيرات في خلايا الدم البيضاء (يظهر ذلك في فحوصات الدم) مما قد يؤدي إلى العدوى المتكررة<br />- انخفاض في الصفائح الدموية بما يؤدي إلى النزيف أو الإصابة بالكدمات بسهولة عن المعتاد.<br />الآثار الجانبية الأخرى (معدل تكرارها غير معلوم)<br />- انتفاخ الثدي عند الرجال<br />- احتباس السوائل<br />- انخفاض مستوى الصوديوم في الدم مما قد يؤدي إلى التعب ، الإرتباك، ارتعاش العضلات، تشنجات،<br />غيبوبة<br />- المرضى الذين سبق لهم التعرض لمشاكل في الكبد فمن النادر جدا إصابتهم بمرض الاعتلال الدماغي<br />(مرض يصيب المخ)<br />لا تقلق بشأن قائمة الآثار الجانبية المذكورة أعلاه فقد لا تصاب بأي من هذه الآثار.<br />إذا وصلت أي من هذه الآثار الجانبية لدرجة الخطورة أو لاحظت ظهور آثار جانبية أخرى لم تذكر في<br />هذه النشرة، يرجى استشارة الطبيب أو الصيدلي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيداً عن متناول الأطفال.<br />يحفظ في درجة حرارة لا تزيد عن ۲٥ درجة مئوية. يحفظ بعيداً عن الضوء.<br />بعد انتهاء تاريخ الصلاحية المدون على العبوة الكارتونية وشريط الأقراص. &trade; لا تستخدم رابيزول<br />لا ينبغي التخلص من الأدوية عبر بالوعات الصرف أو ضمن مخلفات المنزل. اسأل الصيدلي الخاص بك<br />عن طريقة التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه التدابير في حماية البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ماذا يحتوي رابيزول<br />۱۰ ملجم على ۱۰ ملجم من المادة الفعالة رابيبرازول صوديوم. &trade; يحتوي كل قرص من رابيزول<br />۲۰ ملجم على ۲۰ ملجم من المادة الفعالة رابيبرازول صوديوم. &trade; يحتوي كل قرص من رابيزول<br />المكونات الأخرى هي:<br />،K- بوفيدون 30 ، (Avicel) ليودبريس ،كروس بوفيدون، أكسيد المغنيسيوم، ميكرو كريستلين سليلوز<br />ستيرات المغنيسيوم، ، (Aerosil هيدروكسي بروبيل سليلوز، ثاني أكسيد السيليكون الصمغي ( ۲۰۰<br />أوبادري أبيض،<br />هيدروكسيد الصوديوم، الأمونيا ۳۰ ٪، الاكريليك-إز، ،(Aqoat HF) AS هيدروكسي بروبيل سليلوز<br />ماء نقي.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>وما هي محتويات العبوة ؟ &trade; كيف يبدو رابيزول<br />۱۰ ملجم : أقراص مغلفة مقاومة للعصارة الهضمية ، ثنائية التحدب لونها أبيض إلي أصفر &trade; رابيزول<br />على الجانبين بالحبر الأسود. &#39; JP فاتح مطبوع &#39; 52<br />۲۰ ملجم : أقراص مغلفة مقاومة للعصارة الهضمية ، ثنائية التحدب لونها أبيض إلي أصفر &trade; رابيزول<br />على الجانبين بالحبر الأسود. &#39; JP فاتح مطبوع &#39; 53<br />۱۰ ملجم عبوة تحتوى على ۲ شريط كل شريط يحتوى على ۷ أقراص معوية التغليف. &trade; رابيزول<br />۲۰ ملجم عبوة تحتوى على ۲ شريط كل شريط يحتوى على ۷ أقراص معوية التغليف. &trade; رابيزول<br />قد لا تكون كل أحجام العبوات مطروحة بالسوق.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>اسم وعنوان مالك رخصة التسويق و المصنع:<br />شركة مصنع جمجوم للأدوية، جدة، المملكة العربية السعودية<br />+۹٦٦-۱۲- ۹٦٦ + فاكس: ٦۰۸۱۲۲۲ -۱۲- الهاتف: ٦۰۸۱۱۱۱<br />www.jamjoompharma.com : الموقع الإلكتروني<br />للإبلاغ عن أي أثار جانبيه:<br />&bull; المملكة العربية السعودية:<br />- المركز الوطني للتيقظ و السلامة الدوائية<br />+۹٦٦-۱۱-۲۰٥- فاكس: ۷٦٦۲ o<br />للإتصال بالإدارة التنفيذية للتيقظ وإدارة الأزمات. o<br />+۹٦٦-۱۱- هاتف: ۲۰۳۸۲۲۲<br />۲۳٤۰-۲۳۳٤-۲۳٥٤-۲۳٥۳-۲۳٥٦- تحويلة: ۲۳۱۷<br />الهاتف المجاني: ۸۰۰۲٤۹۰۰۰۰ o<br />npc.drug@sfda.gov.sa : بريد إلكتروني o<br />www.sfda.gov.sa/npc : الموقع الالكتروني o<br />&bull; دول الخليج الأخرى:<br />- الرجاء الاتصال بالمؤسسات و الهيئات الوطنية في كل دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            01/2017
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Rabezole 10 mg Enteric Coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 10 mg of Rabeprazole sodium.
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Enteric Coated Tablets
Off white to pale yellow colored biconvex enteric-coated tablets imprinted 'JP 52' on both side with
black ink.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rabeprazole tablets are indicated for the treatment of:<br />Active duodenal ulcer<br />Active benign gastric ulcer<br />Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD).<br />Gastro-Oesophageal Reflux Disease Long-term Management (GORD Maintenance)<br />Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic<br />GORD)<br />Zollinger-Ellison Syndrome.<br />In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter<br />pylori in patients with peptic ulcer disease. See section 4.2.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adults/older people:<br />Active Duodenal Ulcer and Active Benign Gastric Ulcer: The recommended oral dose for both active<br />duodenal ulcer and active benign gastric ulcer is 20mg to be taken once daily in the morning.<br />Most patients with active duodenal ulcer heal within four weeks. However a few patients may require<br />an additional four weeks of therapy to achieve healing. Most patients with active benign gastric ulcerheal within six weeks. However again a few patients may require an additional six weeks of therapy to<br />achieve healing.<br />Erosive or Ulcerative Gastro-Oesophageal Reflux Disease (GORD): The recommended oral dose for<br />this condition is 20mg to be taken once daily for four to eight weeks.<br />Gastro-Oesophageal Reflux Disease Long-term Management (GORD Maintenance): For long-term<br />management, a maintenance dose of Rabeprazole 20 mg or 10 mg once daily can be used depending<br />upon patient response.<br />Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic<br />GORD): 10mg once daily in patients without oesophagitis. If symptom control has not been achieved<br />during four weeks, the patient should be further investigated. Once symptoms have resolved,<br />subsequent symptom control can be achieved using an on-demand regimen taking 10mg once daily<br />when needed.<br />Zollinger-Ellison Syndrome: The recommended adult starting dose is 60 mg once a day. The dose may<br />be titrated upwards to 120 mg/day based on individual patient needs. Single daily doses up to 100<br />mg/day may be given. 120 mg dose may require divided doses, 60 mg twice daily. Treatment should<br />continue for as long as clinically indicated.<br />Eradication of H. pylori: Patients with H. pylori infection should be treated with eradication therapy.<br />The following combination given for 7 days is recommended.<br />Rabeprazole 20mg twice daily + clarithromycin 500mg twice daily and amoxicillin 1g twice daily.<br />For indications requiring once daily treatment Rabeprazole tablets should be taken in the morning,<br />before eating; and although neither the time of day nor food intake was shown to have any effect on<br />rabeprazole sodium activity, this regimen will facilitate treatment compliance.<br />Patients should be cautioned that the Rabeprazole tablets should not be chewed or crushed, but should<br />be swallowed whole.<br />Renal and hepatic impairment:<br />No dosage adjustment is necessary for patients with renal or hepatic impairment.<br />See section 4.4 Special Warnings and Precautions for Use of Rabeprazole in the treatment of patients<br />with severe hepatic impairment.<br />Children:<br />Rabeprazole is not recommended for use in children, as there is no experience of its use in this group.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Rabeprazole is contra-indicated in patients with known hypersensitivity to rabeprazole sodium, or to
any excipient used in the formulation. Rabeprazole is contra-indicated in pregnancy and during breast
feeding.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptomatic response to therapy with Rabeprazole sodium does not preclude the presence of gastric or<br />oesophageal malignancy, therefore the possibility of malignancy should be excluded prior to<br />commencing treatment with Rabeprazole<br />Patients on long-term treatment (particularly those treated for more than a year) should be kept under<br />regular surveillance.<br />A risk of cross-hypersensitivity reactions with other proton pump inhibitor or substituted<br />benzimidazoles cannot be excluded.<br />Patients should be cautioned that Rabeprazole tablets should not be chewed or crushed, but should be<br />swallowed whole.<br />Rabeprazole is not recommended for use in children, as there is no experience of its use in this group.<br />There have been post marketing reports of blood dyscrasias (thrombocytopenia and neutropenia). In the<br />majority of cases where an alternative aetiology cannot be identified, the events were uncomplicated<br />and resolved on discontinuation of rabeprazole.<br />Hepatic enzyme abnormalities have been seen in clinical trials and have also been reported since market<br />authorisation. In the majority of cases where an alternative aetiology cannot be identified, the events<br />were uncomplicated and resolved on discontinuation of rabeprazole.<br />No evidence of significant drug related safety problems was seen in a study of patients with mild to<br />moderate hepatic impairment versus normal age and sex matched controls. However because there are<br />no clinical data on the use of Rabeprazole in the treatment of patients with severe hepatic dysfunction<br />the prescriber is advised to exercise caution when treatment with Rabeprazole is first initiated in such<br />patients.<br />Co-administration of atazanavir with Rabeprazole is not recommended (see section 4.5).<br />Treatment with proton pump inhibitors, including Rabeprazole, may possibly increase the risk of<br />gastrointestinal infections such as Salmonella, Campylobacter and Clostridium difficile (see section<br />5.1).Proton pump inhibitors, especially if used in high doses and over long durations (&gt;1 year), may<br />modestly increase the risk of hip, wrist and spine fracture, predominantly in older people or in presence<br />of other recognised risk factors. Observational studies suggest that proton pump inhibitors may increase<br />the overall risk of fracture by 10&ndash;40%. Some of this increase may be due to other risk factors. Patients<br />at risk of osteoporosis should receive care according to current clinical guidelines and they should have<br />an adequate intake of vitamin D and calcium.<br />Severe hypomagnesaemia has been reported in patients treated with proton pump inhibitors like<br />Rabeprazole for at least three months, and in most cases for a year. Serious manifestations of<br />hypomagnesaemia such as fatigue, tetany, delirium, convulsions, dizziness and ventricular arrhythmia<br />can occur but they may begin insidiously and be overlooked. In most affected patients,<br />hypomagnesaemia improved after magnesium replacement and discontinuation of the proton pump<br />inhibitor.<br />For patients expected to be on prolonged treatment or who take proton pump inhibitors with digoxin or<br />drugs that may cause hypomagnesaemia (e.g., diuretics), health care professionals should consider<br />measuring magnesium levels before starting proton pump inhibitor treatment and periodically during<br />treatment.<br />Concomitant use of Rabeprazole with Methotrexate<br />Literature suggests that concomitant use of PPIs with methotrexate (primarily at high dose; see<br />methotrexate prescribing information) may elevate and prolong serum levels of methotrexate and/or its<br />metabolite, possibly leading to methotrexate toxicities. In high-dose methotrexate administration, a<br />temporary withdrawal of the PPI may be considered in some patients.<br />Influence on vitamin B12 absorption<br />Rabeprazole sodium, as all acid-blocking medicines, may reduce the absorption of vitamin B12<br />(cyanocobalamin) due to hypo- or a- chlorhydria. This should be considered in patients with reduced<br />body stores or risk factors for reduced vitamin B12 absorption on long-term therapy or if respective<br />clinical symptoms are observed.<br />Subacute cutaneous lupus erythematosus (SCLE)<br />Proton pump inhibitors are associated with very infrequent cases of SCLE. If lesions occur, especially<br />in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help<br />promptly and the health care professional should consider stopping Rabeprazole SCLE after previous&nbsp;inhibitors.<br />Interference with laboratory tests<br />Increased Chromogranin A (CgA) level may interfere with investigations for neuroendocrine tumours.<br />To avoid this interference, Rabeprazole treatment should be stopped for at least 5 days before CgA<br />measurements (see section 5.1). If CgA and gastrin levels have not returned to reference range after<br />initial measurement, measurements should be repeated 14 days after cessation of proton pump inhibitor<br />treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rabeprazole sodium produces a profound and long lasting inhibition of gastric acid secretion. An<br />interaction with compounds whose absorption is pH dependent may occur. Co-administration of<br />rabeprazole sodium with ketoconazole or itraconazole may result in a significant decrease in antifungal<br />plasma levels. Therefore individual patients may need to be monitored to determine if a dosage<br />adjustment is necessary when ketoconazole or itraconazole are taken concomitantly with Rabeprazole<br />In clinical trials, antacids were used concomitantly with the administration of Rabeprazole and, in a<br />specific drug-drug interaction study, no interaction with liquid antacids was observed.<br />Co-administration of atazanavir 300 mg/ritonavir 100 mg with omeprazole (40 mg once daily) or<br />atazanavir 400 mg with lansoprazole (60 mg once daily) to healthy volunteers resulted in a substantial<br />reduction in atazanavir exposure. The absorption of atazanavir is pH dependent. Although not studied,<br />similar results are expected with other proton pump inhibitors. Therefore PPIs, including rabeprazole,<br />should not be co-administered with atazanavir (see Section 4.4).<br />Methotrexate<br />Case reports, published population pharmacokinetic studies, and retrospective analyses suggest that<br />concomitant administration of PPIs and methotrexate (primarily at high dose; see methotrexate<br />prescribing information) may elevate and prolong serum levels of methotrexate and/or its metabolite<br />hydroxymethotrexate. However, no formal drug interaction studies of methotrexate with PPIs have<br />been conducted.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy:<br />There are no data on the safety of rabeprazole in human pregnancy.<br />Reproduction studies performed in rats and rabbits have revealed no evidence of impaired fertility or<br />harm to the foetus due to rabeprazole sodium, although low foeto-placental transfer occurs in rats.<br />Rabeprazole is contraindicated during pregnancy.<br />Breast-feeding:<br />It is not known whether rabeprazole sodium is excreted in human breast milk. No studies in breastfeeding<br />women have been performed. Rabeprazole sodium is however excreted in rat mammary<br />secretions. Therefore Rabeprazole should not be used during breast-feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Based on the pharmacodynamic properties and the adverse events profile, it is unlikely that<br />Rabeprazole would cause an impairment of driving performance or compromise the ability to use<br />machinery. If however, alertness is impaired due to somnolence, it is recommended that driving and<br />operating complex machinery be avoided.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported adverse drug reactions, during controlled clinical trials with rabeprazole<br />were headache, diarrhoea, abdominal pain, asthenia, flatulence, rash and dry mouth. The majority of<br />adverse events experienced during clinical studies were mild or moderate in severity, and transient in<br />nature.<br />The following adverse events have been reported from clinical trial and post-marketing experience.<br />Frequencies are defined as: common (&gt; 1/100, &lt; 1/10), uncommon (&gt; 1/1,000, &lt; 1/100), rare<br />(&gt;1/10,000, &lt;1/1000) very rare (&lt;1/10,000), Not Known (cannot be estimated from the available data).<br />System Organ<br />Class Common Uncommon Rare Very Rare Not Known<br />Infections and<br />infestations Infection<br />Blood and the<br />lymphatic system<br />disorders<br />Neutropenia<br />Leucopenia<br />Thrombocytopenia</p><p>Leucocytosis<br />Immune system<br />disorders Hypersensitivity1,2<br />Metabolism and<br />nutrition<br />disorders Anorexia<br />Hyponatremia<br />Hypomagnesaemia4<br />Psychiatric<br />disorders Insomnia Nervousness Depression Confusion<br />Nervous system<br />disorders<br />Headache<br />Dizziness Somnolence<br />Eye disorders Visual disturbance<br />Vascular<br />Disorders Peripheral Oedema<br />Respiratory,<br />thoracic and<br />mediastinal<br />disorders<br />Cough<br />Pharyngitis<br />Rhinitis<br />Bronchitis<br />Sinusitis<br />Gastrointestinal<br />disorders<br />Diarrhoea<br />Vomiting<br />Nausea<br />Abdominal<br />pain<br />Constipation<br />Flatulence<br />Fundic Gland<br />Polyps<br />(Benign)<br />Dyspepsia<br />Dry mouth<br />Eructation<br />Gastritis<br />Stomatitis<br />Taste disturbance<br />Hepato-biliary<br />disorders<br />Hepatitis<br />Jaundice<br />Hepatic<br />encephalopathy3<br />Skin and<br />subcutaneous<br />tissue disorders<br />Rash<br />Erythema2<br />Pruritus<br />Sweating<br />Bullous reactions2<br />Erythema<br />multiforme,<br />toxic<br />epidermal<br />necrolysis<br />(TEN),<br />Stevens-<br />Johnson<br />syndrome<br />(SJS)<br />Subacute cutaneous<br />lupus<br />erythematosus4<br />Musculoskeletal Non-specific Myalgia&nbsp;connective tissue<br />and bone<br />disorders<br />pain<br />Back pain<br />Leg cramps<br />Arthralgia<br />Fracture of the<br />hip, wrist or<br />spine 4<br />Renal and<br />urinary disorders<br />Urinary tract<br />infection<br />Interstitial<br />nephritis<br />Reproductive<br />system and<br />breast disorders Gynaecomastia<br />General<br />disorders and<br />administration<br />site conditions<br />Asthenia<br />Influenza like<br />illness<br />Chest pain<br />Chills<br />Pyrexia<br />Investigations<br />Increased hepatic<br />enzymes3 Weight increased<br />1 Includes facial swelling, hypotension and dyspnoea<br />2 Erythema, bullous reactions and hypersensitivity reactions have usually resolved after discontinuation<br />of therapy.<br />3 Rare reports of hepatic encephalopathy have been received in patients with underlying cirrhosis. In<br />treatment of patients with severe hepatic dysfunction the prescriber is advised to exercise caution when<br />treatment with Rabeprazole is first initiated in such patients (see section 4.4).<br />4 See Special warnings and precautions for use (4.4)<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br /> Fax: +966-11-205-7662<br /> Call NPC at +966-11-2038222,<br />Exts: 2317-2356-2353-2354-2334-2340.<br /> Toll free phone: 8002490000<br /> E-mail: npc.drug@sfda.gov.sa<br /> Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Experience to date with deliberate or accidental overdose is limited. The maximum established<br />exposure has not exceeded 60mg twice daily, or 160mg once daily. Effects are generally minimal,&nbsp;representative of the known adverse event profile and reversible without further medical intervention.<br />No specific antidote is known. Rabeprazole sodium is extensively protein bound and is, therefore, not<br />dialysable. As in any case of overdose, treatment should be symptomatic and general supportive<br />measures should be utilised.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Alimentary tract and metabolism, Drugs for peptic ulcer and gastrooesophageal<br />reflux disease (GORD), proton pump inhibitors, ATC code: A02B C04<br />Mechanism of Action: Rabeprazole sodium belongs to the class of anti-secretory compounds, the<br />substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonist properties,<br />but suppress gastric acid secretion by the specific inhibition of the H+/K+-ATPase enzyme (the acid or<br />proton pump) The effect is dose-related and leads to inhibition of both basal and stimulated acid<br />secretion irrespective of the stimulus. Animal studies indicate that after administration, rabeprazole<br />sodium rapidly disappears from both the plasma and gastric mucosa. As a weak base, rabeprazole is<br />rapidly absorbed following all doses and is concentrated in the acid environment of the parietal cells.<br />Rabeprazole is converted to the active sulphenamide form through protonation and it subsequently<br />reacts with the available cysteines on the proton pump.<br />Anti-secretory Activity: After oral administration of a 20mg dose of rabeprazole sodium the onset of<br />the anti-secretory effect occurs within one hour, with the maximum effect occurring within two to four<br />hours. Inhibition of basal and food stimulated acid secretion 23 hours after the first dose of rabeprazole<br />sodium are 69% and 82% respectively and the duration of inhibition lasts up to 48 hours. The inhibitory<br />effect of rabeprazole sodium on acid secretion increases slightly with repeated once-daily dosing,<br />achieving steady state inhibition after three days. When the drug is discontinued, secretory activity<br />normalises over 2 to 3 days.<br />Decreased gastric acidity due to any means, including proton pump inhibitors such as rabeprazole,<br />increases counts of bacteria normally present in the gastrointestinal tract. Treatment with proton pump&nbsp;inhibitors may possibly increase the risk of gastrointestinal infections such<br />as Salmonella, Campylobacter and Clostridium difficile.<br />Serum Gastrin Effects: In clinical studies patients were treated once daily with 10 or 20mg rabeprazole<br />sodium, for up to 43 months duration. Serum gastrin levels increased during the first 2 to 8 weeks<br />reflecting the inhibitory effects on acid secretion and remained stable while treatment was continued.<br />Gastrin values returned to pre-treatment levels, usually within 1 to 2 weeks after discontinuation of<br />therapy.<br />Human gastric biopsy specimens from the antrum and the fundus from over 500 patients receiving<br />rabeprazole or comparator treatment for up to 8 weeks have not detected changes in ECL cell histology,<br />degree of gastritis, incidence of atrophic gastritis, intestinal metaplasia or distribution of H. pylori<br />infection. In over 250 patients followed for 36 months of continuous therapy, no significant change in<br />findings present at baseline was observed.<br />Other Effects: Systemic effects of rabeprazole sodium in the CNS, cardiovascular and respiratory<br />systems have not been found to date. Rabeprazole sodium, given in oral doses of 20mg for 2 weeks, had<br />no effect on thyroid function, carbohydrate metabolism, or circulating levels of parathyroid hormone,<br />cortisol, oestrogen, testosterone, prolactin, cholecystokinin, secretin, glucagon, follicle stimulating<br />hormone (FSH), luteinising hormone (LH), renin, aldosterone or somatotrophic hormone.<br />Studies in healthy subjects have shown that rabeprazole sodium does not have clinically significant<br />interactions with amoxicillin. Rabeprazole does not adversely influence plasma concentrations of<br />amoxicillin or clarithromycin when co-administered for the purpose of eradicating upper<br />gastrointestinal H. pylori infection.<br />During treatment with antisecretory medicinal products, serum gastrin increases in response to the<br />decreased acid secretion. Also CgA increases due to decreased gastric acidity. The increased CgA level<br />may interfere with investigations for neuroendocrine tumours.<br />Available published evidence suggests that proton pump inhibitors should be discontinued between 5<br />days and 2 weeks prior to CgA measurements. This is to allow CgA levels that might be spuriously<br />elevated following PPI treatment to return to reference range.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption: Rabeprazole is an enteric-coated (gastro-resistant) tablet formulation of rabeprazole<br />sodium. This presentation is necessary because rabeprazole is acid-labile.<br />Absorption of rabeprazole therefore begins only after the tablet leaves the stomach. Absorption is rapid,<br />with peak plasma levels of rabeprazole occurring approximately 3.5 hours after a 20mg dose. Peak<br />plasma concentrations (Cmax) of rabeprazole and AUC are linear over the dose range of 10mg to<br />40mg. Absolute bioavailability of an oral 20mg dose (compared to intravenous administration) is about<br />52% due in large part to pre-systemic metabolism. Additionally the bioavailability does not appear to<br />increase with repeat administration. In healthy subjects the plasma half-life is approximately one hour<br />(range 0.7 to 1.5 hours), and the total body clearance is estimated to be 283 &plusmn; 98 ml/min. There was no<br />clinically relevant interaction with food. Neither food nor the time of day of administration of the<br />treatment affect the absorption of rabeprazole sodium.<br />Distribution: Rabeprazole is approximately 97% bound to human plasma proteins.<br />Metabolism and excretion: Rabeprazole sodium, as is the case with other members of the proton pump<br />inhibitor (PPI) class of compounds, is metabolised through the cytochrome P450 (CYP450) hepatic<br />drug metabolising system. In vitro studies with human liver microsomes indicated that rabeprazole<br />sodium is metabolised by isoenzymes of CYP450 (CYP2C19 and CYP3A4). In these studies, at<br />expected human plasma concentrations rabeprazole neither induces nor inhibits CYP3A4; and although<br />in vitro studies may not always be predictive of in vivo status these findings indicate that no interaction<br />is expected between rabeprazole and cyclosporin. In humans the thioether (M1) and carboxylic acid<br />(M6) are the main plasma metabolites with the sulphone (M2), desmethyl-thioether (M4) and<br />mercapturic acid conjugate (M5) minor metabolites observed at lower levels. Only the desmethyl<br />metabolite (M3) has a small amount of anti-secretory activity, but it is not present in plasma.<br />Following a single 20mg 14C labelled oral dose of rabeprazole sodium, no unchanged drug was<br />excreted in the urine. Approximately 90% of the dose was eliminated in urine mainly as the two<br />metabolites: a mercapturic acid conjugate (M5) and a carboxylic acid (M6), plus two unknown<br />metabolites. The remainder of the dose was recovered in faeces.&nbsp;&nbsp;Gender: Adjusted for body mass and height, there are no significant gender differences in<br />pharmacokinetic parameters following a single 20 mg dose of rabeprazole.<br />Renal dysfunction: In patients with stable, end-stage, renal failure requiring maintenance haemodialysis<br />(creatinine clearance &le;5ml/min/1.73 m2), the disposition of rabeprazole was very similar to that in<br />healthy volunteers. The AUC and the Cmax in these patients was about 35% lower than the<br />corresponding parameters in healthy volunteers. The mean half-life of rabeprazole was 0.82 hours in<br />healthy volunteers, 0.95 hours in patients during haemodialysis and 3.6 hours post dialysis. The<br />clearance of the drug in patients with renal disease requiring maintenance haemodialysis was<br />approximately twice that in healthy volunteers.<br />Hepatic dysfunction: Following a single 20 mg dose of rabeprazole to patients with chronic mild to<br />moderate hepatic impairment the AUC doubled and there was a 2-3 fold increase in half-life of<br />rabeprazole compared to the healthy volunteers. However, following a 20 mg dose daily for 7 days the<br />AUC had increased to only 1.5-fold and the Cmax to only 1.2-fold. The half-life of rabeprazole in<br />patients with hepatic impairment was 12.3 hours compared to 2.1 hours in healthy volunteers. The<br />pharmacodynamic response (gastric pH control) in the two groups was clinically comparable.<br />Older people: Elimination of rabeprazole was somewhat decreased in older people. Following 7 days of<br />daily dosing with 20mg of rabeprazole sodium, the AUC approximately doubled, the Cmax increased<br />by 60% and t&frac12; increased by approximately 30% as compared to young healthy volunteers. However<br />there was no evidence of rabeprazole accumulation.<br />CYP2C19 Polymorphism: Following a 20mg daily dose of rabeprazole for 7 days, CYP2C19 slow<br />metabolisers, had AUC and t&frac12; which were approximately 1.9 and 1.6 times the corresponding<br />parameters in extensive metabolisers whilst Cmax had increased by only 40%.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical effects were observed only at exposures sufficiently in excess of the maximum human<br />exposure that make concerns for human safety negligible in respect of animal data.Studies on mutagenicity gave equivocal results. Tests in mouse lymphoma cell line were positive, but in<br />vivo micronucleus and in vivo and in vitro DNA repair tests were negative. Carcinogenicity studies<br />revealed no special hazard for humans.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ludipress, Crospovidone, Magnesium oxide, Microcrystalline Cellulose (Avicel),<br />Povidone K-30, Hydroxypropylcellulose, Colloidal Silicon Dioxide (Aerosil 200),<br />Magnesium Stearate, Opadry White, Hydroxypropylcellulose AS (Aqoat HF), Sodium Hydroxide,<br />Ammonia 30 % , Acryl-eze, Purified Water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25&deg;C. Protect from Light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Alu - Alu blister</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jamjoom Pharmaceuticals Company
P.O. Box 6267
Jeddah 21442
Tel +966126081111
Fax +966126081222.
Kingdom of Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                07/2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>